Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of ₹1,546 Crore up from ₹1,430.47 Crore year on year, a growth of 8%. The Consolidated Net Profit of ₹107.84 Crore, down 45% from ₹196.96 Crore in the same quarter of the previous year. The Earnings per Share is ₹4.25 for this quarter.
Ipca Laboratories Limited Q3 FY23; Revenue Increased To ₹1,546 Crore
Tags: pharmaceuticals
Related Post
- Titan Company Ltd Q2FY25; 1.5% fall in Net Profits
Company Overview: Titan Company Ltd is among India’s most respected lifestyle companies. It has established…
-
Coal India Ltd Q2FY25; 22% fall in Profits
Coal India Ltd is mainly engaged in mining and production of Coal and also operates…
-
Cholamandalam Investment & Finance Company Ltd Q2FY25; 25% rise in Profits
Cholamandalam Investment & Finance Company is one of the premier diversified non-banking finance companies in…